Polianta LTD Amgen Inc Transaction History

Polianta LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 17, 2019	SELL	$166.7 - $195.41 $1.5 Million - $1.76 Million	-9,000 Closed	0 $0
Q1 2019 Apr 04, 2019	BUY	$180.87 - $203.88 $75,965 - $85,629	420 Added 4.9%	9,000 $1.71 Million
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $335,392 - $391,510	1,880 Added 28.06%	8,580 $1.67 Million
Q1 2018 Apr 13, 2018	BUY	$169.43 - $198.0 $1.14 Million - $1.33 Million	6,700 New	6,700 $1.14 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.